Lisa Schlager is a recognized consumer advocacy leader for the hereditary cancer community. As Vice President of Community Affairs & Public Policy (2010-present), Ms. Schlager manages strategic partnerships and collaborations for FORCE, a national nonprofit dedicated to the hereditary cancer community. She also spearheads the organization’s legislative and regulatory policy efforts, advocating for the unique needs of the high-risk cancer community. Well-versed in health care and genetic privacy laws—i.e. Genetic Information Nondiscrimination Act (GINA), Women’s Health and Cancer Rights Act (WHCRA), Affordable Care Act, etc.—Schlager is the point person on national guidelines and advocacy issues affecting the hereditary cancer community. She possesses expert knowledge on policies impacting, and insurance coverage of, screening and preventive services for individuals at increased risk of cancer and targeted treatments for those diagnosed with hereditary cancers. Ms. Schlager holds leadership positions with a number of cancer and health care initiatives in the government, nonprofit, and private sectors. In recent years, she has served as a consumer advisor for the FDA Patient-Focused Drug Development Initiative; PCORI grant reviewer; Co-Chair of the PCORnet Patient & Consumer Engagement Steering Committee; Project Manager for the ABOUT Patient-Powered Research Network; Partner Manager for the CDC-funded XRAYS program; Personalized Medicine Coalition advisory board member, and more. Schlager represents FORCE and the hereditary cancer community as an expert speaker at conferences, events, and in the media.